Latest Shareholder Dilution News

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

Everest Metals is set to begin toll processing at its Mt Dimer Gold Project in September 2026, backed by strong mining progress and promising high-grade drill results.

Thor Energy reported a robust cash position of A$2.8 million at June 30, 2026, and confirmed natural hydrogen concentrations up to 3% at its HY-Range Project. The company awarded a fully funded 464 line-kilometre 2D seismic survey to Velseis, marking a key step towards drilling.

Cavalier Resources has lifted the net present value of its Crawford Gold Project by 50%, securing a $23 million financing package and advancing pre-production activities as it moves closer to development.

The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.

Genmin has locked in A$3 million in unsecured director loans to fund working capital for its Baniaka iron ore project, avoiding immediate shareholder dilution while advancing project financing.

Australian Gold and Copper Ltd (ASX: AGC) has completed the second tranche of its $5 million placement, received a nearly $1 million R&D tax refund, and finalized the acquisition of the drill-ready Junee gold project in NSW.

Anson Resources has secured the initial tranche of a AUD 7.2 million facilitation fee from POSCO, advancing the Green River Lithium Project’s Direct Lithium Extraction demonstration plant in Utah.

Sarama Resources has offloaded its Western Australian gold projects to Riedel Resources for A$3.2 million in cash and shares, securing a substantial equity stake and executive influence in the buyer while limiting shareholder dilution amid its arbitration claim.

Aldoro Resources has secured A$4.3 million through unsecured convertible notes, providing funding to accelerate development at its Kameelburg Critical Minerals Project and exploring a potential Hong Kong Stock Exchange listing.

Toubani Resources (ASX: TRE) has launched the retail tranche of its fully underwritten A$70 million entitlement offer at A$0.30 per share, following a successful institutional raise, to fund the Kobada Gold Mine’s construction and exploration.

Starpharma Holdings is raising approximately $32 million through a fully underwritten 1-for-7.5 renounceable entitlement offer priced at $0.57 per share, discounting the stock by 25%. Proceeds will fund the DEP HER2-Lu Phase 1 trial and expand its dendrimer-based oncology pipeline.